IGF-1 and Growth Response to Adult Height in a Randomized GH Treatment Trial in Short Non-GH-Deficient Children

被引:31
|
作者
Kristrom, Berit [1 ,3 ]
Lundberg, Elena [1 ]
Jonsson, Bjorn [2 ]
Albertsson-Wikland, Kerstin [3 ]
机构
[1] Umea Univ, Dept Clin Sci, SE-90185 Umea, Sweden
[2] Uppsala Univ, Dept Womens & Childrens Hlth, SE-75185 Uppsala, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Goteborg Pediat Growth Res Ctr,Dept Pediat, SE-41685 Gothenburg, Sweden
来源
基金
瑞典研究理事会;
关键词
IDIOPATHIC SHORT STATURE; FOR-GESTATIONAL-AGE; LONG-TERM MORTALITY; HORMONE TREATMENT; BINDING PROTEIN-3; FACTOR-I; PREPUBERTAL CHILDREN; FINAL HEIGHT; SECRETION CAPACITIES; PREDICTION MODELS;
D O I
10.1210/jc.2014-1101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: GH treatment significantly increased adult height (AH) in a dose-dependent manner in short non-GH-deficient children in a randomized, controlled, clinical trial; the mean gain in height SD score (height(SDS)) was 1.3 (range 0-3), compared with 0.2 in the untreated group. Objective: The objective of the study was to analyze the relationship between IGF-1(SDS), IGF binding protein-3 SDS (IGFBP3(SDS)), and their ratio(SDS) with a gain in the height(SDS) until AH in non-GH-deficient short children. Design and Setting: This was a randomized, controlled, multicenter clinical trial. Intervention: The intervention included GH treatment: 33 or 67 mu g/kg.d plus untreated controls. Subjects: One hundred fifty-one non-GH-deficient short children were included in the intent-to-treat (ITT) population and 108 in the per-protocol (PP) population; 112 children in the ITT and 68 children in the PP populations had idiopathic short stature (ISS). Main Outcome Measures: Increments from baseline to on-treatment study mean IGF-1(SDS) (Delta IGF-1(SDS)), IGFBP3(SDS), and IGF-1 to IGFBP3 ratio(SDS) were assessed in relationship to the gain in height(SDS). Results: Sixty-two percent of the variance in the gain in height(SDS) in children on GH treatment could be explained by four variables: Delta IGF-1(SDS) (explaining 28%), bone age delay, birth length (the taller the better), and GH dose (the higher the better). The lower IGF-1(SDS) was at baseline, the higher was its increment during treatment. For both the All(PP)- and the ISSPP-treated groups, the attained IGF-1(SDS) study level did not correlate with height gain. Conclusion: In short non-GH-deficient children, the GH dose-related increment in IGF-1(SDS) from baseline to mean study level was the most important explanatory variable for long-term growth response from the peripubertal period until AH, when IGF-1(SDS), IGFBP3(SDS), and their ratio(SDS) were compared concurrently.
引用
收藏
页码:2917 / 2924
页数:8
相关论文
共 50 条
  • [31] Study on the Relationship Between the Growth and Development Speed and the Expression of GH and IGF-1 in Children
    QUE Yong-xiang
    ZHANG Ling-zhao
    ZHANG Sheng-can
    YOU Qiu-xia
    Chinese Journal of Biomedical Engineering, 2023, 32 (01) : 25 - 31
  • [32] Growth hormone (GH) treatment in non-GH deficient chronic disease
    Richton, SM
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1998, 17 (05) : 405 - 406
  • [33] Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency
    Perez-Colon, Sheila
    Lazareva, Oksana
    Purushothaman, Radhika
    Malik, Shahid
    Ten, Svetlana
    Bhangoo, Amrit
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 16 (03)
  • [34] Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak
    Feldt-Rasmussen, Ulla
    Brabant, Georg
    Maiter, Dominique
    Jonsson, Bjorn
    Toogood, Andy
    Koltowska-Haggstrom, Maria
    Rasmussen, Aase Krogh
    Buchfelder, Michael
    Saller, Bernhard
    Biller, Beverly M. K.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (05) : 733 - 743
  • [35] CORRELATION OF GH BIOACTIVITY TO IGF-1 AND HEIGHT IN GIRLS WITH TURNER SYNDROME.
    Foster, C. M.
    Kietter, G. B.
    Hopwood, N. J.
    Beitins, I. Z.
    PEDIATRIC RESEARCH, 1993, 33 (SUPPL 5) : S58 - S58
  • [36] Correlation between GH and IGF-1 during treatment for acromegaly
    Oldfield, Edward H.
    Jane, John A., Jr.
    Thorner, Michael O.
    Pledger, Carrie L.
    Sheehan, Jason P.
    Vance, Mary Lee
    JOURNAL OF NEUROSURGERY, 2017, 126 (06) : 1959 - 1966
  • [37] Correlation between IGF-1 at diagnosis and adult height in children with short stature
    Incandela, Valeria
    Lussu, Anna
    Guzzetti, Chiara
    Ibba, Anastasia
    Loche, Sandro
    Casula, Letizia
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 520 - 521
  • [38] Phenotypic Features and Response to GH Treatment of Patients With a Molecular Defect of the IGF-1 Receptor
    Walenkamp, Marie J. E.
    Robers, Jasmijn M. L.
    Wit, Jan M.
    Zandwijken, Gladys R. J.
    van Duyvenvoorde, Hermine A.
    Oostdijk, Wilma
    Hokken-Koelega, Anita C. S.
    Kant, Sarina G.
    Losekoot, Monique
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08): : 3157 - 3171
  • [39] IGF-1 generation test in non-growth hormone-deficient short children
    Likitmaskul, S
    Watcharasindhu, S
    Angsusingha, K
    Chaichanwatanakul, K
    Punnakunta, L
    Tuchinda, C
    HORMONE RESEARCH, 1998, 49 : 52 - 52
  • [40] Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
    Felicio, Joao Soares
    Janau, Luisa Correa
    Moraes, Marcelle Alves
    Zahalan, Nathalie Abdallah
    Resende, Fabricio de Souza
    de Lemos, Manuela Nascimento
    de Souza Neto, Norberto Jorge Kzan
    Farias de Franco, Isabela Imbelloni
    Costa Leitao, Loyane Tamyres
    d'Albuquerque Silva, Lilian de Souza
    Neres Iunes de Oliveira, Maria Clara
    de Alcantara, Angelica Leite
    Contente Braga de Souza, Ana Carolina
    da Silva, Wanderson Maia
    dos Santos, Marcia Costa
    Marques de Queiroz, Natercia Neves
    de Moraes, Lorena Vilhena
    de Figueiredo Jr, Antonio Bentes
    Prieto Farinassi, Ana Luiza
    da Costa Farias, Luciana Marques
    da Silva, Danielle Dias
    Felicio, Karem Mileo
    Abrahao Neto, Joao Felicio
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10